The best Side of "3
All enrolled patients who acquired at the very least a person dose of zosuquidar or placebo during induction had been monitored to the incidence of adverse events (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse functions ended up related to the period of extended and major myelosuppression as is expected with induc